Guest guest Posted December 23, 2008 Report Share Posted December 23, 2008 "Taking a new medicine is the start of a new experiment." Nowhere is this truer than with the statin class of drugs. Although the majority of statin users appear to do well, the collateral damage of this class of drug is such that diverse symptoms, reflecting multiple metabolic pathways, can be expected. This is from Doc Gravelines site http://www.spacedoc.net/genetic_susceptibility_statins.html Please help stop email address harvesting and subsequent spamming & protect your family, friends and yourself. Use BCC when sending to multiple email addresses and also delete old email addresses BEFORE forwarding on emails. Thank you. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.